Value investors spend a great deal of energy looking for mispricings in individual companies. The harder skill is recognizing when the market has misfiled an entire category of risk as resolved when, in fact, the clock is still running. That is what is happening today across three separate pressure points, each with a hard expiration date between now and early November. Equities are priced for resolution. The evidence suggests something closer to the opposite.
The Hormuz MoU: A Deal That Has Already Broken Down Twice
The mid-June 2026 memorandum of understanding between the U.S. and Iran was designed to pause fighting for 60 days while both sides negotiated a broader settlement, including provisions tied to freedom of navigation in the Strait of Hormuz. It did not hold. In early July, the conflict resumed after Iran attacked three commercial vessels that bypassed its approved route. President Trump declared the ceasefire “over” following the attacks. The U.S. retaliated, launching further strikes against Iran “to further degrade their ability to threaten freedom of navigation in the Strait of Hormuz,” according to U.S. Central Command.
By late July the shooting had not stopped. Brent climbed above $92 per barrel late last week as fighting flared again. Regional mediators reportedly proposed a 10-day ceasefire to restart negotiations, but ING strategists warned the task would not be easy, noting that “large divisions remain between the US and Iran.”
The conflict has also spread beyond the strait itself. The conflict has expanded beyond Hormuz into the Red Sea, where Iran-backed Houthi rebels in Yemen threatened to blockade Saudi Arabia, prompting Riyadh to join U.S. forces in launching strikes on targets in Iraq linked to Tehran-backed militants. Meanwhile, the U.S. Strategic Petroleum Reserve declined for an eighteenth straight week in mid-July, falling to its lowest level since 1983.
Wells Fargo Investment Institute put the investment consequence plainly: “Until something changes with the status of the Strait, we believe the bias remains for higher oil prices and, in turn, higher expected inflation and interest rates, and episodes of equity price volatility.” That is not a temporary read. It is a structural one. Energy names, defense contractors, and any company with energy-cost-sensitive margins are carrying embedded assumptions about a stable Hormuz that the market itself has already proven wrong twice in two months.
September Is a Live Meeting, Not a Formality
The July FOMC vote is being discussed as a hold. It was more complicated than that. The policy committee voted 9-3 to keep rates at 3.5%-3.75%. A trio of policymakers dissented in favor of a hike, the most seen since September 2016. The dissenting votes came from regional presidents Beth Hammack of Cleveland, Neel Kashkari of Minneapolis, and Lorie Logan of Dallas.
BMO Capital Markets’ head of U.S. rates Ian Lyngen read the result as “a Committee with vocal hawks, but the majority is siding with Warsh to keep rates stable until at least September when policymakers will have the benefit of the July and August CPI reports.” That framing matters. September is not a holding pattern; it is the next real decision point.
Markets are leaning toward a September hike, based on Fed funds futures pricing tracked by CME Group, as hawkish signals mount. Those signals include rising bond yields, recent hawkish speeches, three July dissents from Fed policymakers, and energy pricing remaining generally elevated. The Fed’s June projections showed nine participants expecting at least one hike in 2026, with the other nine projecting rates to be unchanged or lower by year-end.
The inflation arithmetic gives the hawks reasonable ground to stand on. U.S. inflation eased to 3.5% in June, marking its first decline in five months. That improvement was heavily influenced by energy. With Brent back near $90, that relief may already be fading. If inflation were to reignite amid escalations in the U.S.-Iran war, it could raise the probability of a hike later in 2026. As EY-Parthenon chief economist Gregory Daco put it: “The September FOMC meeting could become the first meaningful test of whether the recent improvement in inflation proves durable.”
Chair Kevin Warsh has been notably reluctant to provide traditional forward guidance, which means September carries genuine surprise risk. The sectors most exposed are those whose 2026 valuations assume no further tightening: utilities, REITs, high-multiple growth, and anything carrying significant floating-rate debt. An unexpected hike compresses multiples before the Q3 earnings season even begins.
November 10: The Rare Earth Deadline Nobody Is Watching
Of the three risks, this one has generated the least market attention. That is precisely the point.
There is not a publicly documented APEC agreement in Busan in October 2025 that sets a November 10, 2026 expiration for a rare earth stand-down. What is clear is that China’s April 2025 rare earth export licensing restrictions created ongoing supply-chain risk, and subsequent pauses or truces have not removed the underlying licensing architecture. Independent analysis, including from CSIS, has argued that even when restrictions are suspended, China is not a reliable export partner to the United States during periods of heightened geopolitical tension. The key point for investors is that the licensing regime and enforcement capacity remain in place, even when the political temperature cools.
The supply concentration that makes this consequential is not subtle. China remains the dominant processor of rare earths and the key choke point for heavy rare earth processing and magnet supply chains. Global diversification remains gradual and capital-intensive, with China expected to retain a dominant position in processing and magnet manufacturing through the decade.
Three potential policy outcomes are plausible whenever a political truce or pause approaches renewal: extension of the pause, selective tightening targeting specific elements or end uses, and broader reimposition of restrictions. Selective reinstatement is possible through an existing licensing framework. Critically, the April 2025 licensing regime was not a temporary headline. Manufacturers dependent on dysprosium, terbium, and yttrium face continued supply chain risk even now, as licensing can ease conditions only partially.
A CSIS one-year assessment of the April 2025 controls identified a structural pattern: “Even if China continues to suspend its export restrictions going into 2027, it is not a reliable export partner to the United States during times of heightened geopolitical tensions.” Because this is ultimately a negotiating issue rather than settled final policy, Beijing could still extend any pause or broaden general licensing for trusted civilian customers. But the enforcement architecture China has established suggests the era of routine commercial rare earth exports without detailed political and end-use scrutiny is ending.
There is no publicly confirmed November 10, 2026 deadline tied to a formal, announced rare earth suspension agreement. The clock that matters is the one embedded in licensing, politics, and enforcement, and the market too often treats a temporary easing as permanent.
What Disciplined Investors Do With Unpriced Deadlines
The common thread across all three situations is not that catastrophe is inevitable. It is that the market is pricing these risks as though the favorable outcome is already confirmed, when the evidence supports no such conclusion.
The Hormuz MoU has broken down twice and oil has moved sharply, dipping into the $70s earlier in the summer before rebounding toward the $90s as fighting resumed. The FOMC voted 9-3 in July, with three dissenters wanting to move immediately. The rare earth risk remains live because the licensing and enforcement machinery is still in place, even when officials signal temporary relief.
Partial outcomes in each case move markets materially. Sustained Hormuz disruption adds meaningful pressure to Brent at a moment when the SPR buffer is at its lowest since 1983. A September hike compresses expensive multiples heading into Q3 earnings. A selective tightening of rare earth export licensing triggers supply chain warnings from semiconductor, defense, and electric vehicle manufacturers that can flow through to guidance well beyond 2026.
The businesses best positioned across all three scenarios share identifiable qualities: pricing power that holds under cost pressure, limited reliance on imported Chinese inputs, proprietary technology that cannot be replicated with lower-cost materials, and balance sheets that do not depend on cheap capital to generate returns. That is a narrower universe than most investors currently hold. Identifying it before September is the exercise.
Value investing is often described as buying quality at a discount. The other half of that work is recognizing when quality is being threatened by risks that markets have been too comfortable ignoring. Three deadlines are running simultaneously right now. The question is not whether they resolve well or badly. The question is whether your portfolio is priced as if the answer is already known.